Filter Results:
(104)
Show Results For
- All HBS Web (135)
- Faculty Publications (32)
Show Results For
- All HBS Web (135)
- Faculty Publications (32)
Sort by
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
coming of age of biotechnology. The disappearance of "blockbuster" drugs could create new management challenges for pharmaceutical companies. — Gary Pisano The prospect is exhilarating, but the road to this brave new biotech... View Details
- 16 Oct 2013
- Op-Ed
Response to Readers: Combating Climate Change with Nuclear Power and Fracking
supply contamination, etc.), as long as production takes place in a state or other legal jurisdiction with a history of sensible oil and gas production regulations and regulatory capacity in-place to enforce those regulations. “Cleaning... View Details
- 09 Mar 2020
- Research & Ideas
Warring Algorithms Could Be Driving Up Consumer Prices
The widespread use of pricing algorithms is reshaping the nature of competition in online markets and potentially driving up the prices of retail goods, according to recent research. These automated, price-adjusting software programs may also be catching the eye of... View Details
- 31 Oct 2004
- Research & Ideas
Bypass Marketing: Are Docs Influenced?
Until the close of the last decade, health consumers received much of their knowledge and advice about prescription drugs from their physicians or other health care professionals. Today, pharmaceutical companies are spending several... View Details
Keywords: by Manda Salls
- 13 Jul 2009
- Research & Ideas
Diagnosing the Public Health Care Alternative
onto patients. To work, a public plan must be regulated and have independent governance, and, if it is well-designed, it might inspire competition from private insurers—leading to better value for patients. Regina E. Herzlinger, The Nancy... View Details
- 23 Mar 2010
- First Look
First Look: March 23
and responding to adverse drug reactions suggests that only government regulators are in a position to integrate case report and statistical analysis. Despite the appeal of fragmented post-market View Details
Keywords: Martha Lagace
- 14 Apr 2021
- Research & Ideas
The High Cost of the Slow COVID Vaccine Rollout
the United States, the Federal Drug Administration this week advised states to pause the use of the Johnson & Johnson vaccine after six women developed a rare blood-clotting disorder, raising new concerns about total vaccine supply.... View Details
- 27 Mar 2012
- First Look
First Look: March 27
Emissions Regulation Authors:David Drake, Paul R. Kleindorfer, and Luk N. Van Wassenhove Abstract We study the impact of emissions tax and emissions cap-and-trade regulation on a firm's long-run technology... View Details
Keywords: Carmen Nobel
- 22 May 2020
- In Practice
Post-COVID Health Care: More Screens, Less Red Tape?
Fetter, a senior lecturer, is former CEO of Tenet Healthcare. Regulations that limit care might be loosened Richard Hamermesh: Cutting the red tape in diagnostic testing The crisis has revealed the weakest part of our medical system—the... View Details
Keywords: by Danielle Kost
- 12 Oct 2006
- First Look
First Look: October 12, 2006
http://www.hbs.edu/research/pdf/07-021.pdf Coerced Confessions: Self-Policing in the Shadow of the Regulator Authors:Jodi L. Short and Michael W. Toffel Abstract As part of a recent trend toward more cooperative relations between View Details
Keywords: Sean Silverthorne
- 11 May 2010
- First Look
First Look: May 11
United States, expanding coverage and regulating insurers. However, it was not clear that expanding coverage would resolve a longstanding dilemma of rising costs for insurance and care. As the Department of Health and Human Services... View Details
Keywords: Martha Lagace
- 30 Oct 2007
- First Look
First Look: October 30, 2007
Changing Context of Pharmaceutical Risk Mitigation Author:Arthur A. Daemmrich Periodical:Pharmacy in History 49, no. 2 (2007): 61-75 Abstract In the wake of Vioxx, Avandia, and other recent prominent cases of drugs found to cause side... View Details
Keywords: Sean Silverthorne
- 26 Feb 2019
- First Look
New Research and Ideas, February 26, 2019
Howard, Sara J. Singer, and Amy C. Edmondson Abstract— For too long, the worlds of business and health have been mired in a checkered, sometimes contentious, history. Millions of deaths worldwide can be attributed to risk factors including tobacco use, alcohol and... View Details
Keywords: Dina Gerdeman
- 30 Mar 2010
- First Look
First Look: March 30
in formulating environmental regulations in three areas: automotive emissions for health related (criteria) pollutants, packaging waste, and global climate change. Automotive emissions are relatively centralised in both political systems.... View Details
Keywords: Sean Silverthorne
- 25 Feb 2014
- First Look
First Look: February 25
in the country's economy during the past two decades, have brought together a group of economists and political scientists to systematically examine the impact of a wide range of factors affecting the economy's collapse, from the cost of labor View Details
Keywords: Sean Silverthorne
- 12 May 2008
- Research & Ideas
Accounting Information as Political Currency
developed and fast-developing nations. Data on legislative-election vote shares are also likely available for many jurisdictions. The data on cash contributions from companies to politicians will be tricky—the United States has relatively better disclosure View Details
Keywords: by Martha Lagace
- 17 Oct 2006
- First Look
First Look: October 17, 2006
find support for these hypotheses. Download working paper: http://www.hbs.edu/research/pdf/07-022.pdf Resolving Information Asymmetries in Markets: The Role of Certified Management Programs Author: Michael W. Toffel Abstract Firms and View Details
Keywords: Sean Silverthorne
- 15 Apr 2014
- First Look
First Look: April 15
from the U.S. Food and Drug Administration (FDA) ordering the company to halt the sale and promotion of its genetic testing kit. The FDA stated that the product was marketed as a diagnostic and preventative tool and that it was subject to... View Details
Keywords: Sean Silverthorne
- 18 Nov 2014
- First Look
First Look: November 18
innovative drug candidates for testing in patients. Project teams consisted of Pfizer scientists and academics working side-by-side to reduce the time needed to bring a therapeutic drug from the lab to a... View Details
Keywords: Sean Silverthorne
- 22 Aug 2006
- First Look
First Look: August 22, 2006
805-067 Molecular Insight has developed a novel biopharmaceutical to detect heart attacks. The company's unique approach to intellectual property protection uses the Hatch Waxman Act and the Orphan Drug Act. The company is struggling to... View Details
Keywords: Martha Lagace